Abstract:Improving the enrichment of drugs or theranostic agents within tumors is very vital to achieve effective cancer diagnosis and therapy while greatly reducing the dosage and damage to normal tissues. Herein, as a proof of concept, we for the first time report a red light-initiated probe-RNA cross-linking (RLIPRC) strategy that can not only robustly promote the accumulation and retention of the probe in the tumor for prolonged imaging but also significantly inhibits the tumor growth. A near-infrared (NIR) fluorescent probe f-CR consisting of a NIR dye (Cyanine 7) as a signal reporter, a cyclic-(arginine-glycine-aspartic acid) (cRGD) peptide for tumor targeting, and a singlet oxygen (1O2)-sensitive furan moiety for RNA cross-linking was rationally designed and synthesized. This probe possessed both passive and active tumor targeting abilities and emitted intense NIR/photoacoustic (PA) signals, allowing for specific and sensitive dual-modality imaging of tumors in vivo. Notably, probe f-CR could be specifically and covalently cross-linked to cytoplasmic RNAs via the cycloaddition reaction between furan and adenine, cytosine, or guanine under the oxidation of 1O2 generated in situ by irradiation of methylene blue (MB) with 660 nm laser light, which effectively blocks the exocytosis of the probes resulting in enhanced tumor accumulation and retention. More excitingly, for the first time, we revealed that the covalent cross-linking of probe f-CR to cytoplasmic RNAs could induce severe apoptosis of cancer cells leading to remarkable tumor suppression. This study thus represents the first red light-initiated RNA cross-linking system with high potential to improve the diagnostic and therapeutic outcomes of tumors in vivo.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c10755?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c10755</a>.Synthetic methods, synthetic routes, characterizations of all compounds; UV absorption of CR and TEM of control group; Cy7 fluorescence intensity standard curve; photoacoustic signal intensity of f-CR solutions at different concentrations; hydrated particle size distribution of f-CR; mass spectrum data after f-CR-RNA cross-linking; cross-linking efficiency under the different MB concentrations; difference of f-CR uptake in 3T3 and 4T1 cells; cells uptake changes of probes at different time points; cytotoxicity of MB; the capability of MB to produce ROS; electrophoresis to investigate RNA in the nucleus; protein electrophoresis to investigate the total proteins in the whole cell; fluorescence intensity change of tumors in vivo at different time points; apoptotic evaluation; weight measurement of the isolated tumor after the different combination treatments, including Schemes S1–S3, Figures S1–S28, Table S1, and RNA information (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c10755/suppl_file/ja0c10755_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

NIR Light-Activated Mitochondrial RNA Cross-Linking Strategy for H 2 S Monitoring and Prolonged Colorectal Tumor Imaging

Biomimetic Multifunctional Persistent Luminescence Nanoprobes for Long-Term Near-Infrared Imaging and Therapy of Cerebral and Cerebellar Gliomas

Sulfenic Acid-Mediated On-Site-specific Immobilization of Mitochondrial-Targeted NIR Fluorescent Probe for Prolonged Tumor Imaging.

NIR Light‐Mediated Mitochondrial RNA Modification for Cancer RNA Interference Therapeutics

β-Galactosidase-Activated and Red Light-Induced RNA Modification Strategy for Prolonged NIR Fluorescence/PET Bimodality Imaging

Red Light-Initiated Cross-Linking of NIR Probes to Cytoplasmic RNA: An Innovative Strategy for Prolonged Imaging and Unexpected Tumor Suppression

NAD(P)H-triggered Probe for Dual-Modal Imaging During Energy Metabolism and Novel Strategy of Enhanced Photothermal Therapy in Tumor.

A Novel Near-Infrared Theranostic Probe for Accurate Cancer Chemotherapy in Vivo by a Dual Activation Strategy

Imaging of Colorectal Cancers Using Activatable Nanoprobes with Second Near‐Infrared Window Emission

Visible and Near-Infrared Dual-Emission Carbogenic Small Molecular Complex with High RNA Selectivity and Renal Clearance for Nucleolus and Tumor Imaging

Hydrogen Sulfide-Activatable Second Near-Infrared Fluorescent Nanoassemblies for Targeted Photothermal Cancer Therapy.

Two birds with one stone: a NIR fluorescent probe for mitochondrial protein imaging and its application in photodynamic therapy

Smart On-Site Immobilizable Near-Infrared II Fluorescent Nanoprobes for Ultra-Long-Term Imaging-Guided Tumor Surgery and Photothermal Therapy

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

A Multifunctional Nanomicelle for Real‐Time Targeted Imaging and Precise Near‐Infrared Cancer Therapy

Rational design of water-dispersible and biocompatible nanoprobes with H<sub>2</sub>S-triggered NIR emission for cancer cell imaging

Redox-Activated Light-Up Nanomicelle for Precise Imaging-Guided Cancer Therapy and Real-Time Pharmacokinetic Monitoring

Activatable Nanoprobes for Dual‐Modal NIR‐II Photoacoustic and Fluorescence Imaging of Hydrogen Sulfide in Colon Cancer

A Tumor-targetable NIR Probe with Photoaffinity Crosslinking Characteristics for Enhanced Imaging-Guided Cancer Phototherapy

An NIR Fluorescent/photoacoustic Dual-Mode Probe of NADPH for Tumor Imaging

Modulation of Near-Infrared Mitochondria-Targetable Fluorescent Probe for H2S Bioimaging Through the Modification of Heavy Atom Iodine.